(Q43762524)

26 November 2017

title

Defective CD2 pathway T cell activation in systemic lupus erythematosus (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

26 October 2022

main subject

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

26 October 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

systemic lupus erythematosus

26 October 2022

1 reference

McCune WJ

8

1 reference

26 November 2017

D. A. Fox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

J. A. Millard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

J. Treisman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

W. Zeldes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

A. Bergman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

J. Depper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

R. Dunne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

W. J. McCune

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673843

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1673843

26 October 2022

publication date

1 May 1991

1 reference

full work available at URL

26 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780340508

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780340508

26 October 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

26 October 2022

published in

Arthritis & Rheumatology

1 reference

26 November 2017

Arthritis and Rheumatism

34

5

561–71

May 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1673843

26 October 2022

volume

34

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

561-571

1 reference

T-lymphocyte subpopulation in untreated SLE. Variations with disease activity

26 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Lymphocyte subpopulations in patients with systemic lupus erythematosus

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features.

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Modulation of the sodium periodate (NaIO4) response in systemic lupus erythematosus (SLE): effect of interleukin-1 (IL-1), interleukin-2 (IL-2), phorbol myristate acetate (PMA), and indomethacin

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Defective induction of T-cell help and natural killing following anti-CD3 stimulation of autoimmune lymphocytes

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus—In vitro immune response to autoantigen

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Defective Concanavalin A-Induced Suppressor Cell Activity in Lupus Nephritis

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Two distinct subsets of patients with systemic lupus erythematosus

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. Preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Subset specificity of antilymhocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4 + cells is associated with relative depletion of autologous T4 + cells

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

26 October 2022

33

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

26 October 2022

38

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

The 1982 revised criteria for the classification of systemic lupus erythematosus

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions

26 October 2022

42

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man

26 October 2022

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

26 October 2022

47

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions

26 October 2022

50

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

26 October 2022

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Defective monocyte function in patients with systemic lupus erythematosus

26 October 2022

54

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Selective inhibition of interleukin 2 gene function following thymocyte antigen/major histocompatibility complex receptor crosslinking: possible thymic selection mechanism

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene

26 October 2022

56

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity

26 October 2022

57

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

CD4+CD45R+ cells are preferentially activated through the CD2 pathway

26 October 2022

58

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

Frequency analysis of human peripheral blood B cells sensitive to CD2 monoclonal antibody-activated T cells

26 October 2022

59

1 reference

https://api.crossref.org/works/10.1002/ART.1780340508

26 October 2022

Identifiers

1 reference

26 November 2017

1 reference